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Puberty—a period when susceptibility to the onset of Type 2 diabetes (T2D) increases—is
marked with profound physiological and metabolic changes. In the EarlyBird cohort,
children who developed impaired fasting glycemia in adolescence already exhibited
higher fasting blood glucose at 5 years of age, independent of their body mass
index (BMI), suggesting that pubertal factors may modify existing predisposition.
Understanding how the physiological changes during childhood influence glucose
homeostasis and how the central energy metabolism may help deciphering the
mechanisms that underlie the risk of developing T2D in children and adults. We
investigated these associations by analyzing glycemic variations with molecular markers
of central energy metabolism, substrate oxidation status and pubertal stages in
the EarlyBird cohort. The EarlyBird study is a non-interventional, prospective cohort
study, that recruited 307 healthy UK children at age 5, and followed them annually
throughout childhood for 12 years. Longitudinal data on blood biochemistry, respiratory
exchange ratio, and anthropometry, available from 150 children were integrated with
fasting glycemia. The gradual rise in blood glucose during childhood associates with
age-dependent changes in molecular processes and substrate oxidation status, namely
(i) greater pre-pubertal fat utilization, ketogenesis, and fatty acid oxidation, and (ii) greater
pubertal carbohydrate oxidation and glycolytic metabolism (Cori and Cahill Cycles)
associated with different amino acid exchanges between muscle and other tissues
(proline, glutamine, alanine). Since children’s metabolic and nutritional requirements
evolve during childhood, this study has potential clinical implications for the development
of nutritional strategies for disease prevention in children.
Keywords: amino acids, biochemistry, glucose, longitudinal study, phenotyping, substrate oxidation, puberty, type
2 diabetes
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INTRODUCTION
Diabetes is now one of the most common non-communicable
diseases in the world, affecting over 422 million people according
to the World Health Organization (WHO) (1). It has been
forecasted that one in every three individuals born in the US
in the year 2000 will develop diabetes during their lifetime (2).
The principal form of diabetes accounting for these projections
is Type 2 diabetes (T2D). As a result of the rising prevalence of
obesity, T2D is a growing concern in children (3), with puberty
being a period of increasing susceptibility to the onset of diabetes
(4, 5).
Normal pubertal growth, along with its underlying
physiological endocrine changes, affects body composition,
muscle mass and strength, and processes including bone
development, erythropoiesis, and substrate utilization (6).
These key physiological processes are accompanied by changes
in biochemical processes, and in turn may influence aerobic
and anaerobic fitness (6). Aerobic fitness increases with the
development of the cardiovascular and respiratory systems,
and skeletal muscle. In addition, anaerobic fitness is influenced
by muscle mass, as well as by size-independent factors (e.g.,
glycolytic metabolism, muscle architecture, neural control),
and tends to increase throughout puberty (7). Such complex
and rapid changes in biochemical and physiological parameters
influence numerous metabolic functions, including total
and resting energy expenditure and physical activity. These
changes may be important in determining susceptibility to the
development of T2D.
Basal metabolism is the energy required for cellular and
tissue maintenance. It increases rapidly up to the age of ∼2
years, and reaches a plateau in late adolescence when growth
velocity and the growth of muscle mass decreases (8). Growth
has additional energy requirements to those of basal metabolism,
and is unique to this early stage of life. Energy cost for growth has
two components; the energy needed for biosynthetic processes in
growing tissues and the energy stores deposited in those tissues
(e.g., fat and protein) (8). The role of resting energy expenditure
and weight gain in children is subject to controversy, with
some evidence that lower energy expenditure may be a factor
predisposing to childhood obesity (9, 10). During adolescence,
the pubertal growth spurt may be associated with a substantial
fall in resting energy expenditure, independent of adiposity (11),
which may influence long-term body composition and metabolic
health outcomes. Food provides macronutrients (carbohydrates,
protein, and fats) that are utilized by the body as sources
of energy.
The EarlyBird study is a landmark prospective cohort study
investigating the origins of T2D in children. This cohort
of healthy children has been followed from age 5 to 16
years with annual clinical, anthropometric, and physiological
measurements (12). A total of 17% of the initially healthy children
in the EarlyBird cohort showed impaired fasting glycemia (IFG)
by the age of 15, a risk factor for future diabetes. The children who
developed IFG already exhibited higher fasting blood glucose
levels at 5 years of age, compared with those who did not
subsequently develop IFG, and this effect was independent of
BMI (12). Recently, we reported that the occurrence of an
early defect in β-cell function among children who go on
to develop prediabetes (12), was genetically determined and
independent of BMI (13). These studies also revealed how
genetic markers are associated with normal glycemic trajectories
during childhood. However, prediabetes did not appear until
puberty, when insulin resistance was at its highest (12). We
successfully applied a longitudinal analysis to explore the
metabolite signatures that precede or follow the development of
greater levels of insulin resistance (IR) during childhood (14, 15).
These analyses provide key insights into metabolite pathways
(ketogenesis, fatty acid oxidation, branched-amino acids), with
distinct patterns according to chronological age, and different
contribution to glucose metabolism (14, 15). In addition, we
reported that interpretation of HbA1c for the diagnosis of
impaired fasting glycemia was limited due to factors other than
glycaemia systematically influencing the variance of HbA1c in
youth (16). Understanding how changes in these molecular
pathways associate with changes in glucose homeostasis and
dietary substrate oxidation in healthy children is necessary to
inform the design of preventive measures, such as individualized
nutritional recommendations.
The aim of the present study was to determine how temporal
glycemic variations during childhood relate to physiological
changes in central energy metabolism and substrate oxidation.
Therefore, we investigated the associations between individual
metabolites, respiratory exchange ratio and fasting glucose
concentrations in the EarlyBird cohort, taking into account




The study was conducted in accordance with the principles of the
Declaration of Helsinki II. Ethical approval was granted by the
Plymouth Local Research Ethics Committee (1999), and parents
gave written consent and children verbal assent. The EarlyBird
Diabetes Study incorporates a 1995/1996 birth cohort recruited
in 2000/2001 when the children were 5 years old (307 children,
170 boys) (17). Most of the children were white Caucasian and
five children out of 307 were of mixed race, reflecting the ethnic
mix of the city of Plymouth. According to the pediatric thresholds
for overweight and obesity proposed by the International Obesity
Task Force (IOTF), 13% of the EarlyBird boys and 26% of
girls were overweight at baseline, which included 4 and 5%,
respectively who were obese. The thresholds approximate to the
91st and 98th centiles of the 1990 BMI reference curves for the
UK, and are deemed to correspond to equivalent thresholds in
adulthood. The collection of data from the EarlyBird cohort is
composed of clinical and anthropometric variables measured on
an annual basis from the age of 5 to 16.
Impaired fasting glycemia was selected as an objective
criterion to identify children with an additional risk for
future diabetes. For blood metabolic phenotyping, subjects were
purposively selected to include children who had shown impaired
fasting glucose at one or more time-points during the course
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of childhood as reported previously (12), and gender-matched
normoglycemic children. A total of 150 participants [63 children
(44 boys and 19 girls) who had shown IFG by age 16 years and
87 children (61 boys and 26 girls) who had not] were selected.
Metabonomics data were available for 130 of these children. Out
of the 55 children who had shown impaired fasting glucose in this
subset, seven had a first degree relative with T2D or T1D.
Anthropometrics
Height and weight were measured every 6 months from age
5 years. BMI was derived from direct measurement of height
(Leicester Height Measure; Child Growth Foundation, London,
U.K.) and weight (Tanita Solar 1632 electronic scales), performed
in duplicate and averaged. BMI SD scores were calculated
from the British 1990 standards (18). Moderate to vigorous
physical activity (MVPA) was measured annually from 5 years
by accelerometry (Acti-Graph) (19). Children were asked to
wear the accelerometers for 7 consecutive days at each annual
follow-up visit, and only recordings that captured at least 4
days (each day incorporating at least 9 h wear time) were used.
Pubertal timing was evaluated by means of age at peak height
velocity (APHV), determined as the tangential velocity at the
middle time point of three consecutive height measurements
taken 6 months apart. Chronologic age does not necessarily
correlate with physiologic or somatic (i.e., related to the body)
pubertal changes (20). The most common way to describe
the sequence of changes in secondary sexual characteristics is
that published by Marshall and Tanner, commonly referred as
Tanner stages (21, 22). The distribution of age at which each
tanner stage was reached for boys and girls is provided in
Supplementary Tables 1, 2, respectively. There are five Tanner
stages. The first stage (Pre-pubertal stage) of puberty begins
around 6–8 years of age, long before any physical changes are
noticeable. The second stage of puberty usually begins around
9–11 years for girls and 11–13 years for boys. However, it is
normal for this to vary by up to 5 years. The second stage
marks the beginning of sexual development and physical changes,
during which boys and girls experience a large growth spurt.
The stages 3 and 4 mark particularly development of secondary
sexual characteristics, whilst the stage 5 marks the end of puberty
and the staging into the body of an adult. Peripheral blood was
collected annually after an overnight fast, blood serum samples
were stored at−80◦C.
Laboratory Assessment
The children were fasted overnight for 10 h before venesection.
The Homeostatic Model Assessment of Insulin Resistance
(HOMA2IR) and the Homeostatic Model Assessment of Beta
Cell Function (HOMA2B) were determined each year from
fasting glucose (Cobas Integra 700 analyzer; Roche Diagnostics)
and insulin (DPC IMMULITE) (cross-reactivity with proinsulin,
1%) using the homeostasis model assessment program, which has
been validated in children (23).
Respiratory Exchange Ratio
Resting energy expenditure wasmeasured by indirect calorimetry
using a ventilated flow through hood technique (Gas Exchange
Measurement, Nutren Technology Ltd, Manchester, UK).
Performance tests reportedly showed a mean error of 0.3± 2.0%
in the measurement of oxygen consumption and 1.8± 1% in that
of carbon dioxide production. Measurements were performed in
a quiet thermoneutral room (20◦C) after an overnight fasting
period of at least 6 h, to minimize any effect attributable to the
thermic effect of food. Data were collected for a minimum of
10min and the respiratory exchange ratio was calculated as an
indicator for substrate oxidation.
Blood Metabolic Profiling
Serum samples collected from each child at every age
between 5 and 16 years old were subjected to metabonomic
analysis. For technical feasibility and to ensure optimal data
reproducibility for cohort analysis, a threshold of 1,800 blood
serum samples (e.g., 150 different subjects) was determined.
Metabolic profiling was carried out by means of proton nuclear
magnetic resonance spectroscopy (1H NMR) spectroscopy, as
reported previously (14, 15). Briefly, 400 µL of blood serum
were mixed with 200 µL of deuterated phosphate buffer
solution 0.6M KH2PO4.
1H NMR metabolic profiles of serum
samples were acquired with a Bruker Avance III 600 MHz
spectrometer equipped with a 5mm cryoprobe at 310K (Bruker
Biospin, Rheinstetten, Germany) and processed using TOPSPIN
(version 2.1, Bruker Biospin, Rheinstetten, Germany) software
package. Based on an internal database of reference compounds,
representative signals of metabolites were integrated. The
signals are expressed in an arbitrary unit corresponding to
a peak area normalized to total metabolic profiles. 1H NMR
spectroscopy being a quantitative method, metabolite peak areas
are proportional to metabolite concentrations, and thus their
changes are representative of absolute change in metabolite
concentrations in the serum. This metabonomics approach
targeted the major metabolic pathways, including central energy
metabolism, amino acids, carboxylic acids, and lipoproteins
and in a highly reproducible manner across more than 1,700
serum samples. In particular, 1H-NMR spectroscopy of human
blood serum enables the monitoring of signals related to
lipoprotein-bound fatty acyl groups found in triglycerides,
phospholipids and cholesteryl esters, together with peaks from
the glyceryl moiety of triglycerides and the choline head group
of phosphatidylcholine.
Statistical Analysis
Mixed effects modeling was used to assess the association
between individual metabolites and fasting glucose, taking
into account age, BMI z-scores, and physical activity.
Controlling for maturational and growth status is crucial in
life course studies, and age at peak height velocity (APHV) is
a key measure of maturity that was also taken into account.
Random intercepts were included as well as age (categorized
to allow for non-linear change in glucose over time), gender,
BMI z-score, APHV, MVPA (number of minutes spent in
moderate-vigorous physical activity), and individual metabolites
(in separate models) as fixed effects. Each metabolite was
transformed to a z-score (i.e., standardized with mean of
0 and standard deviation of 1) for analysis. Modeling was
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carried out in R software (www.R-project.org) using the lmer
function in the package lme4 (24) and p-values calculated
using the Satterthwaite approximation implemented in the
lmerTest package (25). Both unadjusted and Bonferroni-
adjusted p-values are presented. Additional Spearman
Correlation analysis was conducted between fasting glucose
and serum metabolites, HOMA indexes, HbA1c, and respiratory
exchange ratio.
RESULTS
Influence of Chronological Age and
Pubertal Stage on Population
Demographics
Clinical and anthropometric characteristics of the children
for the 12-year period are summarized in Table 1 and
Supplementary Figure 1. For both genders, there was an increase
in fasting glucose throughout childhood, concomitant with
increasing BMI-z-score and respiratory exchange ratio, and
decreasing physical activity (MVPA). As previously reported,
fasting insulin and HOMA-IR decreased until around 8 years,
and then increased during puberty until the age of 14 years,
before decreasing until the age of 16 years. This pattern was
dependent on the time of APHV and BMI z-scores (15).
Mean fasting glucose concentrations increased from 4.3 and
4.4 mmol at age 5, to 5.2 and 5.0 mmol at age 16, for boys and
girls, respectively (Table 1). Interestingly, these increases were
marked by two plateaus, first between 8 and 11 years of age,
then between 13 and 16 years of age (Supplementary Figure 1).
Mirroring the changes in blood glucose concentrations, an
evolving pattern was observed in the RER and age. RQ values
reflect metabolic substrate utilization for energy production.
From age 5 to 7, RER values were around 0.9, and increased
toward their maximum values of 1 between the age of 11
and 13, followed by a slight decrease toward 0.95 from 14
years of age (Supplementary Figure 1). Figure 1 describes the
age-dependent changes in clinical and glycemic parameters in
relation to male and female pubertal development. Parameters
were plotted according to Tanner stage (21, 22). Tanner stage
was self-reported at each time-point, and the same Tanner stage
may be reported at more than one time-point. Therefore, for each
child, the parameter for each Tanner stage is represented once by
selecting only the value at the first occurrence (e.g., for Tanner
Stage 1, values at age 5 were selected).
Longitudinal Association of Fasting
Glucose and Serum Metabolites
Using data at all ages simultaneously, mixed effects modeling
was applied to assess the association between fasting glucose
concentrations and individual metabolites. Several blood
metabolites including amino acids, organic acids, and lipids
showed statistically significant associations with fasting glucose
concentrations in longitudinal models, independently of BMI
z-score, physical activity, and APHV. Data are reported to
statistical significance and in alphabetic order for different
metabolic pathways and metabolites (Table 2).




Fasting glucose (mmol/L−1) 5 4.3 ± 0.4 4.4 ± 0.4
6 4.5 ± 0.4 4.4 ± 0.3
7 4.6 ± 0.5 4.6 ± 0.4
8 4.8 ± 0.3 4.7 ± 0.4
9 4.8 ± 0.5 4.9 ± 0.3
10 4.9 ± 0.3 4.8 ± 0.3
11 4.8 ± 0.4 4.8 ± 0.3
12 4.9 ± 0.4 5.1 ± 0.4
13 5.2 ± 0.3 5.1 ± 0.4
14 5.2 ± 0.3 5.2 ± 0.5
15 5.2 ± 0.3 5.2 ± 0.4
16 5.2 ± 0.3 5.0 ± 0.4
HOMA-IR 5 0.6 ± 0.49 0.81 ± 0.37
6 0.48 ± 0.44 0.63 ± 0.41
7 0.37 ± 0.23 0.46 ± 0.20
8 0.44 ± 0.26 0.60 ± 0.44
9 0.59 ± 0.39 0.89 ± 0.49
10 0.88 ± 0.41 1.15 ± 0.71
11 0.85 ± 0.54 1.19 ± 0.70
12 0.96 ± 0.56 1.89 ± 1.30
13 1.10 ± 0.57 1.61 ± 1.00
14 1.15 ± 0.68 1.57 ± 0.97
15 0.93 ± 0.56 1.45 ± 1.54
16 0.83 ± 0.64 0.96 ± 0.84
Fasting insulin (mU/L−1) 5 4.3 ± 3.5 5.7 ± 2.6
6 3.4 ± 3.2 4.4 ± 2.9
7 2.6 ± 1.5 3.2 ± 1.3
8 3.0 ± 1.7 4.1 ± 3.0
9 4.1 ± 2.7 6.1 ± 3.4
10 6.0 ± 2.9 8.0 ± 5.1
11 5.8 ± 3.8 8.3 ± 4.9
12 6.6 ± 3.9 13.1 ± 9.2
13 7.4 ± 4.0 11 ± 6.9
14 7.7 ± 4.7 10.7 ± 6.6
15 6.3 ± 3.7 9.9 ± 10.9
16 5.6 ± 4.4 6.6 ± 5.9
BMI Z-scores 5 0.22 ± 1.1 0.3 ± 1.23
6 0.19 ± 0.99 0.58 ± 0.96
7 0.23 ± 1.06 0.64 ± 0.93
8 0.2 ± 0.92 0.46 ± 1.04
9 0.33 ± 1.05 0.57 ± 0.98
10 0.33 ± 1.04 0.72 ± 1.11
11 0.33 ± 1.11 0.66 ± 1.16
12 0.37 ± 1.16 0.75 ± 1.16
13 0.49 ± 1.21 0.86 ± 1.21
14 0.33 ± 1.16 0.86 ± 1.17
15 0.37 ± 1.12 0.89 ± 1.25
16 0.51 ± 1.13 0.87 ± 1.14
Moderate-vigorous physical
activity (min/day)
5 55.1 ± 19.9 46.2 ± 26.6
(Continued)
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6 61.9 ± 23.6 54.8 ± 17.5
7 63 ± 24.1 52.6 ± 17.2
8 61.3 ± 23.1 46.7 ± 15
9 60.9 ± 23.9 40.8 ± 17.3
10 59.1 ± 26.5 37.2 ± 14.7
11 57.3 ± 27.4 34.3 ± 20.2
12 59.6 ± 27.5 35.2 ± 19.6
13 55.1 ± 23.9 36.4 ± 22.2
14 49.5 ± 26.6 40.6 ± 30.4
15 48.3 ± 23.6 31.6 ± 18.1
16 44.5 ± 23.7 32.1 ± 22.9
Respiratory exchange ratio 5 0.89 ± 0.09 0.92 ± 0.06
6 0.88 ± 0.08 0.88 ± 0.09
7 0.90 ± 0.06 0.92 ± 0.08
8 0.97 ± 0.09 0.99 ± 0.09
9 0.95 ± 0.1 0.96 ± 0.14
10 0.95 ± 0.1 0.93 ± 0.1
11 1.01 ± 0.07 1.01 ± 0.07
12 0.99 ± 0.06 1.00 ± 0.07
13 1.00 ± 0.07 1.02 ± 0.09
14 0.96 ± 0.08 0.96 ± 0.09
15 0.95 ± 0.3 0.93 ± 0.09
16 0.95 ± 0.15 0.95 ± 0.09






Age at peak height is reported as median with interquartile range, and other data are
reported as mean +/- standard deviation.
Of note, the analysis described positive associations of alanine
and lactate with fasting glucose. In addition, the LDL and
VLDL-related blood lipid signature was positively associated
with fasting glucose concentrations throughout childhood. Most
other amino acid metabolites, HDL and phosphocholine-related
lipids were negatively associated with fasting glucose throughout
childhood. The analysis also described how blood ketone bodies
(3-D-hydroxybutyrate, acetoacetate), Krebs cycle intermediates
(citrate, formate), glycine-related metabolites (dimethylglycine,
creatine, creatinine) were negatively associated with the fasting
glucose trajectories.
Age Dependent Correlation of Blood
Metabolites With Fasting Glucose
Additional cross-sectional correlation analysis of metabolites,
insulin traits, HbA1c, respiratory exchange ratio, and BMI-z-
scores with fasting glucose for each year was conducted using
Spearman rank correlation. Data for the 12-year period were
reported using heatmaps in Figure 2, for which the variables are
ordered according to the temporal profile of their correlation
with fasting glucose.
The heatmap plot highlights the negative correlations of α-
keto-isovalerate, 3-methyl-2-oxovalerate, 2-ketobutyrate, 3-D-
hydroxybutyrate, acetoacetate, citrate, and leucine with fasting
glucose at each age, throughout childhood. In addition, positive
associations of glucose with alanine, lactate, LDL, and VLDL
related blood lipids were observed in the early years, between 5
and 9 years of age.
The same correlation analysis using HbA1c as
endpoint variable was also performed and reported in
Supplementary Figure 2. Fasting glucose and HbA1c showed
positive correlations during childhood, and similar correlation
patterns are observed between metabolites and fasting glucose
and HbA1c. Yet, fasting glucose shows stronger statistically
significant correlation with metabolites, and with insulin and
insulin resistance, than HbA1c during childhood.
Metabolite Changes According to Pubertal
Stages and Metabolic Pathways
Major changes in levels of blood serum metabolites suggested
changes in protein and amino acid levels, as well as lipid
metabolic pathways. Therefore, blood biochemical patterns
involved in central carbon metabolism, branched chain amino
acids (BCAA), fatty acid oxidation, and ketogenesis were
displayed according to their respective metabolic pathways
(Figure 3, Supplementary Figures 3–5). Data are reported as a
function of the pubertal stages for boys and girls.
Such a data visualization illustrates a rapid decrease in the level
of ketogenesis from the early pubertal stages. These changes were
associated with decreased levels of acetate, formate and the major
Krebs cycle intermediate citrate, and are indicative of a profound
remodeling of fatty acid oxidation in children’s metabolism
during the transition from early childhood to adolescence. In
contrast to the changes in lipid metabolism, glucose and alanine
concentrations increased steadily during puberty, whilst lactate
concentration increased primarily in the early period of pubertal
development. Such variations in blood biochemical profiles
probably reflect changes in energy and carbohydrate metabolism
during puberty, with alanine and lactate concentrations reflecting
changing activity in the Cori and Cahill cycles.
Throughout puberty, changes in amino acid metabolism
are more complex. Overall, children show a decreased blood
concentration of several compounds, including glutamate,
arginine, and glycine. In addition, complex patterns in the
metabolism of branched amino acids (BCAA) are described.
Whilst circulating levels of BCAA catabolic products decreased
during puberty, circulating levels of BCAA evolved differently,
and seemed to exhibit sexual dimorphism (e.g., Valine)
(Supplementary Figure 3). Of note, several other blood amino
acid profiles displayed distinct differences between boys and
girls in late puberty. For instance, boys showed a distinct
increase in glutamine and proline in late puberty, whilst
girls showed decreases in histidine, asparagine, and citrulline
(Supplementary Figure 4). Finally, creatinine metabolism shows
a consistent pattern throughout puberty, with creatinine
concentrations increasing steadily, and more markedly in boys
from mid-puberty (Supplementary Figure 5).
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FIGURE 1 | Overview of main glycemic and physiological trajectories in childhood: longitudinal status according to pubertal stage in boys and girls. Data are plotted
as mean ± standard error.
DISCUSSION
As children grow and develop, changes in metabolism are
directly related to total energy requirements (e.g., basal
metabolism, physical activity, and growth) (26). Growth
and development are associated with complex endocrine
changes. In particular, the growth hormone (GH)/insulin-like
growth factor 1 (IGF-1) axis has a fundamental impact on
glucose homeostasis and metabolism throughout childhood,
by influencing glycogenolysis, gluconeogenesis, and lipolysis
(27). This description of puberty-related changes in molecular
processes and substrate utilization for energy production
significantly extends the existing literature. Although HbA1c
retains a positive association with glucose throughout childhood
in our cohort, it is weak, and their trends diverge from 10
years (16). These findings therefore limit the interpretation
of HbA1c for the diagnosis of impaired fasting glycemia
during childhood and suggest that factors other than glycaemia
systematically influence the variance of HbA1c in youth
(16). Our additional study reveals stronger associations of
fasting glycemia with changes in insulin resistance as well as
metabolites when compared to HbA1c, which suggests that
analysis of temporal glycemic variations may encapsulate
more comprehensively the changes in physiological and
metabolite pathways during childhood. In this uniquely
well-characterized cohort of healthy children, the transition
from childhood to adolescence was associated with increasing
fasting glucose concentrations and a complex remodeling of
central energy metabolism, including amino acid and fatty acid
molecular pathways.
In the EarlyBird cohort, the gradual rise in the fasting
respiratory exchange ratio describes an increased carbohydrate
oxidation throughout childhood. Yet, these fasting respiratory
exchange ratio values are high in comparison to adults, where
fasting respiratory exchange ratio would remain between 0.8 and
0.90 (28). Higher fasting respiratory exchange ratio values in
adults (29) and in adolescents (30) may be linked to reduced
metabolic flexibility (i.e., reduced ability to switch from fat
to carbohydrate oxidation). Whilst there is limited published
literature on healthy children, in the Earlybird cohort, we did
not see statistically significant differences in fasting respiratory
exchange ratio between normoglycemic children and those
with impaired fasting glycemia. Since the maximum values
are observed around 11–13 years of age, a period of height
growth spurt and important growth in lean mass tissues,
our observations may suggest a period of reduced metabolic
flexibility during puberty. Finally, a potential limitation in
the interpretation of the respiratory exchange ratio is that
the measurements were conducted in the fasted state, and
conclusions should not necessarily be extrapolated to the post-
prandial state.
Prior to puberty, we identified that pre-pubertal children
oxidize more fat relative to total energy expenditure than
adults and pubertal children, an observation consistent with
previous reports (31). In addition, pre-pubertal children are
known to oxidize fats preferentially over carbohydrates during
low to moderate intensity exercise as well, when compared
with post-pubertal children and adults (32–35). Boisseau et al.
reported that higher fat oxidation in pre-pubertal children
was associated with a distinctive metabolic phenotype, namely
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TABLE 2 | Estimates and p-values from mixed effects models examining the association between metabolites and fasting glucose.







Alcohol Methanol 3.31 −0.004 0.010 0.737 1.000
Amino acid derivatives 2-ketobutyrate 1.07 −0.111 0.012 <0.0001 <0.0001
Amino acid derivatives 3-Methyl-2oxovalericacid 1.08 −0.117 0.012 <0.0001 <0.0001
Amino acid derivatives Alpha-ketoisovalerate 1.14 −0.041 0.012 0.001 0.044
Amino acid derivatives Dimethylglycine 2.93 −0.057 0.013 <0.0001 <0.0001
Amino acid derivatives N-acetyl proteins 2.03 −0.055 0.014 <0.0001 0.003
Amino acid derivatives Taurine 3.29 −0.042 0.012 <0.0001 0.027
Amino acid derivatives Trimethylamine 2.87 −0.066 0.013 <0.0001 <0.0001
Amino acid derivatives Trimethylamine-N-Oxide 3.25 0.027 0.013 0.042 1.000
Amino acids Alanine 1.48 0.050 0.012 <0.0001 0.003
Amino acids Arginine 1.71 −0.096 0.013 <0.0001 <0.0001
Amino acids Asparagine 2.85 −0.087 0.014 <0.0001 <0.0001
Amino acids Citrulline 3.14 −0.045 0.014 <0.0001 0.039
Amino acids Glutamate 2.35 −0.038 0.013 0.004 0.171
Amino acids Glutamine 2.45 −0.027 0.014 0.053 1.000
Amino acids Glycine 3.57 −0.052 0.016 0.001 0.063
Amino acids Histidine 7.06 −0.064 0.013 <0.0001 <0.0001
Amino acids Lysine 1.76 −0.061 0.012 <0.0001 <0.0001
Amino acids Phenylalanine 7.42 −0.038 0.012 0.002 0.093
Amino acids Proline 3.34 0.017 0.014 0.199 1.000
Amino acids Serine 3.96 −0.062 0.014 <0.0001 <0.0001
Amino acids Threonine 4.29 −0.022 0.010 0.036 1.000
Amino acids Tyrosine 7.2 0.008 0.013 0.503 1.000
Branched chain amino acids Isoleucine 1.01 −0.099 0.013 <0.0001 <0.0001
Branched chain amino acids Leucine 0.96 −0.144 0.011 <0.0001 <0.0001
Branched chain amino acids Valine 1.05 −0.112 0.012 <0.0001 <0.0001
Glycolysis related Citrate 2.66 −0.107 0.013 <0.0001 <0.0001
Glycolysis related Glucose 3.25 0.109 0.013 <0.0001 <0.0001
Glycolysis related Lactate 1.33 0.023 0.012 0.049 1.000
Ketone bodies 3-D-Hydroxybutyrate 1.18 −0.158 0.011 <0.0001 <0.0001
Ketone bodies Acetate 1.91 −0.042 0.017 0.015 0.642
Ketone bodies Acetoacetate 2.29 −0.112 0.009 <0.0001 <0.0001
Lipids Lipid (mainly HDL, fatty acid CH3 moieties) 0.83 −0.053 0.015 <0.0001 0.016
Lipids Lipid (mainly HDL, fatty acid (CH2)n moieties) 1.23 −0.004 0.013 0.74 1.000
Lipids Lipid (mainly LDL, fatty acid CH3 moieties) 0.87 0.063 0.014 <0.0001 0.001
Lipids Lipid (mainly LDL, fatty acid (CH2)n moieties) 1.27 0.060 0.014 <0.0001 0.001
Lipids Lipid (mainly VLDL, fatty acid (CH2) moieties) 1.5 0.062 0.014 <0.0001 0.001
Lipids Lipid 1H signal 5.18–5.21 0.031 0.015 0.037 1.000
Lipids Phosphocholine containing lipids 3.21 −0.067 0.016 <0.0001 0.001
Organic acid Creatine 3.93 −0.088 0.016 <0.0001 <0.0001
Organic acid Creatinine 4.05 −0.060 0.014 <0.0001 <0.0001
Organic acid Formate 8.45 −0.064 0.013 <0.0001 <0.0001
Coef, coefficient indicating the directions of the associations between the metabolite and fasting glycemia overtime; SE, standard error for the coefficient.
increased blood free fatty acid and glycerol, which are indicators
of fat mobilization from peripheral stores and increased lipolysis
(35). Our study has also shown that pre-pubertal children have
higher levels of ketogenesis, as noted by higher serum levels of
ketones. Two ketone bodies, namely 3-D-hydroxybutyrate and
acetoacetate, decreased linearly during the first two pubertal
stages for both sexes, to reach minima that remained constant
throughout the rest of childhood. Ketogenesis is generally
stimulated when fatty acid β-oxidation and production of acetyl-
CoA exceeds the processing capacity of the Krebs cycle. The
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FIGURE 2 | Overview of spearman correlations between fasting glucose and other parameters as a function of chronological age. MVPA, moderate to vigorous
physical activity; RER, respiratory exchange ratio.
decreased concentration of serum citrate and formate with
puberty illustrates the decreased contribution of fatty acids to
the pool of acetyl-coA entering the Krebs for energy production.
These patterns describe an overall decreasing fatty acid oxidation,
via β-oxidation and ketogenesis, from pre-pubertal to pubertal
stage. Whereas 3-D-hydroxybutyrate showed the largest decrease
in concentration, levels of acetoacetate remained more stable
(constant levels), which suggests that there may be different
contributions to ketogenesis from protein and lipid metabolism
during puberty.
In addition, serum lipoprotein levels in childhood are known
to vary with age, as a result of the hormonal changes of puberty,
with reports of complex pattern and interactions according
to age, gender and insulin resistance (36–38). Some studies
in normal weight children reported that levels of triglycerides
(mainly in VLDL) increased whereas total cholesterol and LDL-
cholesterol decreased during puberty in both sexes (36, 37).
Other reports describe distinct and gender-specific patterns from
mid-puberty, namely increased triglycerides and decreased HDL
cholesterol in boys, and the opposite pattern in girls (38).
Our observations suggest that changes in the serum LDL and
VLDL fatty acid signature are positively associated with fasting
glycemia throughout childhood. We previously reported how IR
development in the Earlybird cohort was marked by decreased
phospholipids (mainly in HDL particles) and increased LDL fatty
acid signature in both males and females in the EarlyBird cohort
(15). Such an observation further illustrates the remodeling of
lipid mobilization and metabolism that underpins structural
growth and changing energy storage (36, 37).
As puberty commences and progresses, there are major
changes in many physiological processes, which in turn modify
fuel mobilization and utilization (39, 40). Jones and Kostyak
reported higher fat oxidation in children (5–10 years) compared
with adults—an adaptative process that might support normal
growth requirements, such as higher rates of protein synthesis,
lipid storage, and bone growth. Such higher requirements are
captured in dietary recommendations for fat consumption,
which suggest reduction in fat intake from childhood to
adulthood (40, 41). For children 1–3 years of age, and 4–18
years of age, the Acceptable Macronutrient Distribution Range
(AMDR) for total fat is 30–40% of energy, and 25–35% of energy,
respectively (40, 41). In adults, the AMDR for fat has been set at
20–35% of energy (40, 41). The novelmolecular insights into lipid
metabolism before and during puberty, revealed in the present
study, may help to further refine the dietary recommendations
in terms of quantity and quality of lipids required for optimal
growth and development of children before and during puberty.
Girls and boys are indistinguishable in muscle strength
until puberty, at which time strength and aerobic performance
increases more rapidly in boys (7, 20). Our analysis also revealed
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FIGURE 3 | Overview of central energy metabolic pathways with selected blood serum metabolite patterns according to pubertal stages. Data are plotted as mean ±
standard error of metabolite integrals (arbitrary units) and glucose concentration (Mmol/L) measured at the first occurrence of pubertal stages for boys and girls,
respectively.
that serum creatinine increased from mid puberty more rapidly
in boys than in girls, whilst being negatively correlated with
fasting glucose. It is likely that the gender difference in muscle
mass and function is driven primarily by the large difference in
free testosterone concentrations that emerges with the onset of
puberty (42). However, boys are more insulin sensitive than girls,
especially during puberty, and it is possible that differences in
the action of insulin may also contribute to gender difference
in muscle mass and function. The gender-specific pattern of
creatinine was associated with greater increases in serum leucine,
valine, glutamine and proline in boys. Our observations agree
with a recent report on whole blood amino acid patterns in
puberty from the LIFE Child Cohort by Hirschel et al. (43).
Serum creatinine is known to be affected by age, gender, ethnicity,
dietary protein intake, and lean mass (44). During puberty,
the bodies of boys exhibit a different tempo of bone, muscle,
and cartilage/tendon growth, which is reflected in the gender-
specific patterns of creatinine and amino acids. Amino acids
play a major role as building blocks for protein synthesis and
as regulators of key metabolic pathways for cell maintenance
and growth (45). Previous studies reported that during puberty,
growth is driven by maintaining a greater rate of protein
synthesis than that of breakdown (46, 47). Arslanian et al.
described lower protein oxidation and proteolysis during puberty
when compared to pre-puberty, whereas protein synthesis was
unchanged (46). In addition, they showed that during puberty
whole body proteolysis is resistant to suppression by insulin (46).
Blood amino acid concentrations reflect both the availability of
amino acids and changes in amino acid influx or efflux between
muscle and other tissues as a result of their utilization (e.g.,
by protein synthesis) or catabolism (protein turnover) (48, 49).
In particular, proline, alanine, and glutamine are used as a
source of energy metabolism through the anaplerotic pathway
of the Krebs cycle in skeletal muscle (50). Since the efficiency
of carbohydrate oxidation increases during puberty, we may
hypothesize that increasing glycolytic metabolism reduces the
mobilization of these amino acids into the anaplerotic pathway,
and further contributes to higher circulating concentrations. The
observed elevation of blood lactate and alanine concentrations
with age reflects changes in the Cori and Cahill cycles. Since
Cori and Cahill cycle shuttle lactate and alanine from the
muscles to the liver, where the nitrogen enters the urea cycle for
gluconeogenesis, this phenotype further illustrates the pubertal
changes in glycolytic metabolism.
Last, several metabolites of one-carbon metabolism—glycine,
dimethylglycine and creatine—showed a negative association
with fasting glucose trajectories. This transmethylation pathway
closely interconnects choline, betaine and homocysteine
metabolism, and is of major importance for numerous cellular
functions, such as DNA methylation, phosphatidylcholine,
and protein synthesis (51, 52). Previous reports described how
glycine and dimethylglycine metabolism is linked to glucose
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homeostasis and diabetes and may be genetically determined
(53). In particular, lower circulating levels were associated with
lower insulin sensitivity and higher fasting glucose (53), which
is in agreement with our novel observations. With a potential
role of the one-carbon cycle in the developmental origins of T2D
(54), the biological implication of such a signature in the course
of childhood would benefit from further clinical investigations.
It is recognized that there are several potential limitations
with the present study. Importantly, the sample size was limited,
and being an exploratory study, it was not possible to undertake
an a priori power calculation. Furthermore, while less-invasive
methods for measuring IR, such as the HOMA are well-suited
for repeat measurements in cohort studies of children, it is
recognized that a potential limitation is that IR measured by
HOMA correlates only modestly with clamp-derivedmeasures of
IR, and also that HOMA IR already correlates highly with fasting
insulin in normoglycaemic subjects (55, 56). However, if fasting
insulin secretion is impaired, the direction of error is that HOMA
underestimates IR. Despite these acknowledged limitations,
HOMA is considered as a valid method for measuring IR in
pediatric research (57).
CONCLUSION
This study demonstrates that normal pubertal growth and
development is accompanied by complex and extensive
remodeling of metabolism and fuel oxidation, reflecting the
changing energy requirements of puberty. The full complexity
of this process is revealed by blood metabolic profiling.
Fasting glycemia increases steadily throughout childhood and
is accompanied by increasing concentration of insulin and
rising respiratory exchange ratio. These metabolic changes are
influenced by the endocrine changes of puberty, including the
GH/IGF axis. As a result, the fuel economy shifts away from
fatty acid oxidation and toward carbohydrate oxidation. The
metabolic signatures indicate reduced fatty acid oxidation and
ketogenesis, increased flux through Cori and Cahill cycles,
and complex changes in amino acids with gender differences
reflecting the emerging contrasts in body composition. There
are gradual rises in LDL and VLDL particles and remodeling of
one carbon metabolism. All of these changes represent normal
physiological development.
These findings raise the important question at what point do
physiological changes, such as increasing fasting glycemia begin
to have pathophysiological consequences and raise concern for
future cardiometabolic health? It is possible to speculate that the
metabolic changes we have observed, especially the shift away
from fat oxidation, and reduced ketogenesis, is maladaptive in
the context of obesity, and may also be liable to perpetuate
the obese state. Therefore, the reduced metabolic flexibility of
puberty makes this a vulnerable period for excessive weight gain.
Weight gain and obesity further exacerbate the physiological
insulin resistance of puberty and fasting glycemia, and will favor
atherogenic changes in the lipid profile and pathways, such as one
carbon metabolism. This is in line with our other findings which
suggested that weight gain and increasing insulin resistance
will exacerbate hyperglycaemia (15) in adolescence, especially in
those who also have genetic impairment of pancreatic beta cell
function (13, 15).
Finally, these findings will have implications for guidance on
child nutrition. Since fat, protein, and carbohydrate requirements
change during pubertal development, this study suggests that
macronutrient requirements for optimum healthy growth and
development and reduction in risk of cardiometabolic disease
may need to take into account metabolic changes at puberty
and gender differences. We speculate that increasing respiratory
exchange ratio and reduced ketogenesis may justify reduction
in dietary fat relative to carbohydrate at adolescence, in order
to reduce the risks of weight gain and insulin resistance.
This nutritional change might be necessary earlier in girls,
reflecting their earlier onset of puberty and growth spurt. The
avoidance of adolescent weight gain is also emphasized, in
view of the maladaptive metabolic effects of insulin resistance,
and in order to reduce long term cardiometabolic risks.
Since growth and energy metabolism are dependent also on
the presence of small quantities of several micronutrients,
further analyses should explore the potential influence of key
enzyme cofactors on metabonomic profiles and implications
for cardiometabolic risk. This knowledge has the potential to
open-up the development of new and age-specific strategies for
the prevention of cardiometabolic disease in children, through
more evidence-based guidance on lifestyle and personalized
dietary interventions.
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